MCK VCPNYSE:MCK testing 10-week VCP flat base at ATHs.
• Entry: 736.40 stop-limit on ⧁150 % vol
• Risk / Stop: 711 (1 % acct risk)
• Target: 805–820 (3.5 R, 2-4 wk swing)
Thesis: Health-services sector strength + low-beta alpha.
#MCK #trading
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
24.0 EUR
3.05 B EUR
331.89 B EUR
124.54 M
About McKesson Corporation
Sector
Industry
CEO
Brian Scott Tyler
Website
Headquarters
Irving
Founded
1833
FIGI
BBG000JMVMZ9
McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
Related stocks
Factors that include a retrace below resistanceMany oscillators are pointing in this direction, as well as technical analysis. It has been a turbulent few weeks, but in a way, it has consistently put us at a reversal point, making it very difficult for this trend to continue beyond 700 until we see a pullback.
A major correction underway could see 500s againThe catalyst doesn't lie, but neither does the TA. We have clearly pointed out key elements to the significance of how low this can go. Major turning points sit at sub 600, volume, and volatility. This will continue to sell off, but expect a retrieval at some point closest to the low 600s.
MCK - LONG SWINGTRADEStock traders may advise shareholders and help manage portfolios. Traders engage in buying and selling bonds, stocks, futures and shares in hedge funds. A stock trader also conducts extensive research and observation of how financial markets perform. This is accomplished through economic and microec
MCK in Sell ZoneMy trading plan is very simple.
I buy or sell when at three of these events happen:
* Price tags the top or bottom of parallel channel zones
* Money flow spikes beyond it's Bollinger Bands
* Stochastic Momentum Index (SMI) at near oversold overbought level
* Price at Fibonacci levels
So...
Here's
Right in the PocketMcKesson fell right into the Golden Pocket which is where I was hoping the pullback takes us, so I can get in. If you zoom out, you will see that this stock has been a JUGGERNAUT. Bullish here!
Earnings this week but looks overboughtBig buys, overbought, indicators squeezing through the roof, BB at the top, I will be closely monitoring to see if that trendline has the same sort of trend as it continues to since the turn of the year.
Expert Analysis Reveals Key Entry Points!McKesson Corporation (MCK) continues to demonstrate resilience and growth potential, evident from its recent price action and robust financial performance. Here’s a detailed analysis for potential investors.
MCK has been in a steady uptrend, currently trading at $586.34. The stock has shown consist
MCK a large cap medical supply company LONGMCK is a large cap medical supply company- it has experienced respectable earnings reports
and steady growth as medical entities including surgery centers and hospitals are busy catching
up on electric surgeries from the COVID era. It is rising ar or under the second upper VWAP
line. The dual tim
MCK = PERMA-BULL! Long-term buy & hold.Over the past 2 years, MCK has been in a rock-solid, aggressive uptrend, gaining 50% in '22 and 30% in '23. The weekly TTM squeeze just fired LONG (again) for the 4th time in three years. This beast is a case-study in layered AVWAP! You could wait for a pullback (since it is slightly extended fro
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
O
OHIO5283946
OhioHealth Corporation 2.834% 15-NOV-2041Yield to maturity
6.65%
Maturity date
Nov 15, 2041
O
OHIO4991199
OhioHealth Corporation 3.042% 15-NOV-2050Yield to maturity
6.59%
Maturity date
Nov 15, 2050
O
OHIO4991198
OhioHealth Corporation 2.807% 15-NOV-2035Yield to maturity
5.76%
Maturity date
Nov 15, 2035
O
OHIO4991195
OhioHealth Corporation 1.775% 15-NOV-2025Yield to maturity
5.47%
Maturity date
Nov 15, 2025
O
OHIO5283943
OhioHealth Corporation 2.297% 15-NOV-2031Yield to maturity
4.75%
Maturity date
Nov 15, 2031
See all MCK bonds
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MCKESSON DL-,01 stocks are traded under the ticker MCK.
We've gathered analysts' opinions on MCKESSON DL-,01 future price: according to them, MCK price has a max estimate of 700.22 EUR and a min estimate of 624.59 EUR. Watch MCK chart and read a more detailed MCKESSON DL-,01 stock forecast: see what analysts think of MCKESSON DL-,01 and suggest that you do with its stocks.
Yes, you can track MCKESSON DL-,01 financials in yearly and quarterly reports right on TradingView.
MCKESSON DL-,01 is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
MCK earnings for the last quarter are 9.35 EUR per share, whereas the estimation was 9.08 EUR resulting in a 2.98% surprise. The estimated earnings for the next quarter are 6.95 EUR per share. See more details about MCKESSON DL-,01 earnings.
MCKESSON DL-,01 revenue for the last quarter amounts to 83.95 B EUR, despite the estimated figure of 87.16 B EUR. In the next quarter, revenue is expected to reach 81.45 B EUR.
MCK net income for the last quarter is 1.16 B EUR, while the quarter before that showed 849.09 M EUR of net income which accounts for 37.17% change. Track more MCKESSON DL-,01 financial stats to get the full picture.
Yes, MCK dividends are paid quarterly. The last dividend per share was 0.62 EUR. As of today, Dividend Yield (TTM)% is 0.40%. Tracking MCKESSON DL-,01 dividends might help you take more informed decisions.
MCKESSON DL-,01 dividend yield was 0.41% in 2024, and payout ratio reached 10.69%. The year before the numbers were 0.45% and 10.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 26, 2025, the company has 45 K employees. See our rating of the largest employees — is MCKESSON DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MCKESSON DL-,01 EBITDA is 4.40 B EUR, and current EBITDA margin is 1.39%. See more stats in MCKESSON DL-,01 financial statements.
Like other stocks, MCK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MCKESSON DL-,01 stock right from TradingView charts — choose your broker and connect to your account.